OOIR: Observatory of International Research

Papers

(The TQCC of Therapeutic Advances in Psychopharmacology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness	102
Relationship between resilience and mental health among COVID-19 bereaved people: the mediating role of dual process coping	54
History repeating: guidelines to address common problems in psychedelic science	45
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review	38
A rapid clinical response to etifoxine in treatment-resistant obsessive-compulsive disorder: a case report of a patient with comorbid bipolar disorder	26
Comment on: History repeating: guidelines to address common problems in psychedelic science	25
The missing link? Pharmacists’ perspectives on discontinuation of long-term antidepressants: a qualitative study	25
Disrupted emotion regulation and spontaneous neural activity in panic disorder: a resting-state fMRI study	24
Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study	23
Psychotropic medications versus non-pharmacologic approaches for managing behavioural and psychological symptoms in Australian aged care residents with dementia: general practitioners’ and physicians’	22
Adult psychiatrists’ views on clozapine prescribing for schizophrenia in Germany—an online survey	20
Sympathetic activation but not dissociation linked to ketamine’s sustained antidepressant effect	19
Corrigendum to “Managing medical and psychiatric multimorbidity in older patients”	18
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia	17
Reasons for discontinuing and restarting lithium multiple times: a case-register study based on the South London and Maudsley NHS Foundation Trust Clinical Record Interactive Search system	17
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review	17
A description of antipsychotic prescribing patterns on the inpatient behavioral health setting: a multicenter cross-sectional analysis	14
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychoti	14
Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?	14
Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review	13
Corrigendum to “Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis”	11
Exploring the clinical factors affecting lithium dose and plasma level and the effect of brand	10
Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine	10
Corrigendum to ‘Comment on: History repeating: guidelines to address common problems in psychedelic science’	9
Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications	9

Impact of CYP1A , CYP2C19 , CYP2D6 , CYP3A4 , CYP3A5	9
Sex, drugs, and arousal—two randomized trials on the effects of ketamine on sexual arousal and calcarine gyrus activity	9
Healthcare resource savings from administering paliperidone palmitate once every 3 months instead of once every month for schizophrenia: a 12-month mirror-image analysis of real-world population-based	8
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia	8
Psychedelic therapy and postpartum depression: priorities and prospects	8
The interplay between serotonin syndrome and syndrome of inappropriate antidiuresis: a fatal case of acute hyponatremia during treatment with duloxetine, chlorphenamine, amitriptyline, and L-tryptopha	8
Effects of glucagon-like peptide-1 receptor agonists on psychiatric disorders: a systematic review	8
The role of empathy in antidepressant withdrawal	7
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies	7
Anticholinergic action is rarely a good thing	7